{"url_path":"/sec/cue/8-k/2026-06-03/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1645460/0001193125-26-255479-index.html","accession_number":"0001193125-26-255479","cik":"0001645460","ticker":"CUE","issuer_name":"Cue Biopharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1645460/0001193125-26-255479-index.html","primary_entity_key":"0001645460","primary_entity_name":"Cue Biopharma, Inc."},"word_count":230,"has_tables":true,"body_markdown":"Item 5.07. Submission of Matters to a Vote of Security Holders.\n\nThe certified results of the matters voted upon at the Special Meeting, which are more fully described in the Proxy Statement are as follows (where applicable, voting results reflect fractional shares rounded down to the nearest whole share):\n\n1. The Company’s stockholders approved, in accordance with Nasdaq Listing Rule 5635(a), (c) and (d), the issuance of shares of common stock upon the exercise of certain warrants issued by the Company in May 2026 in connection with a licensing transaction and related private placement (“Proposal 1”), with votes cast as follows:\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n1,782,133\n\n \n\n113,311\n\n \n\n1,013\n\n-\n\n \n\n2. The Company’s stockholders approved the 2026 Plan (“Proposal 2”), with votes cast as follows:\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n1,261,296\n\n \n\n632,474\n\n \n\n2,687\n\n-\n\n \n\n \n\n3. The Company’s stockholders approved the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation of proxies in the event that there are insufficient votes for, or otherwise in connection with, Proposal 1 and/or Proposal 2 (“Proposal 3”), with votes cast as follows:\n\n \n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n1,302,751\n\n \n\n582,084\n\n \n\n11,622\n\n-\n\n \n\nBecause there were sufficient votes at the time of the Special Meeting to approve each of Proposal 1 and Proposal 2, a vote on Proposal 3, which was approved, was not necessary or applicable."}